White Elm Capital’s Gilead Sciences GILD Stock Holding History

White Elm Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-282,203	Closed	-$27.7M	–	29
2015 Q3	$27.7M	Sell	282,203 -125,490	-31%	-$13.9M	2.87%	20
2015 Q2	$47.7M	Sell	407,693 -203,500	-33%	-$22.2M	4.84%	5
2015 Q1	$60M	Sell	611,193 -413	-0.1%	-$41.9K	6.44%	4
2014 Q4	$57.6M	Buy	611,606 +284,406	+87%	+$29.4M	5.72%	4
2014 Q3	$34.8M	Buy	+327,200	New	+$32M	3.14%	18

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

White Elm Capital's GILD Position: Q4 2015 in Review

White Elm Capital sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 282,203 shares — an estimated $27.7M sold.

White Elm Capital first reported a position in GILD in Q3 2014 and held it in 5 quarters. The position peaked at $60M in Q1 2015. 1,627 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

White Elm Capital reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
White Elm Capital sold 282,203 Gilead Sciences shares in Q4 2015, an estimated $27.7M.
White Elm Capital first reported a position in Gilead Sciences in Q3 2014 and held it in 5 quarters.
White Elm Capital's Gilead Sciences position peaked at $60M in Q1 2015.
1,627 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on White Elm Capital's 13F filing for Q4 2015, filed 16 Feb 2016.